Novartis Investigative Site
Daugavpils, LVA LV-5417
0 studies enrolling now · 3 studies all time
What they study most
Asthma, Moderate to Severe Plaque-type Psoriasis, Psoriasis
Studies at this site
- Study of Secukinumab With 2 mL Pre-filled Syringes — Completed
- Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma — Completed
- Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed